This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Kwan-Hoo Lee: Innovator in Cancer Treatment
Introduction
Kwan-Hoo Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of non-small cell lung cancer (NSCLC). His innovative work has the potential to impact many lives.
Latest Patents
Kwan-Hoo Lee holds a patent for a composition aimed at preventing and treating non-small cell lung cancer. This composition includes pyrazino-triazine derivatives, an isomer thereof, or a pharmaceutically acceptable salt thereof. The effectiveness of this composition in combating NSCLC is noteworthy, as it offers a promising avenue for treatment.
Career Highlights
Kwan-Hoo Lee is currently associated with Jw Pharmaceutical Corporation, where he continues to advance his research and development efforts. His work at the company reflects his commitment to improving cancer treatment options.
Collaborations
He collaborates with talented colleagues, including Joo-Young Cha and Ji-Eun Jung, who contribute to his research endeavors. Their combined expertise enhances the potential for innovative solutions in the medical field.
Conclusion
Kwan-Hoo Lee's contributions to cancer treatment through his patented composition demonstrate his dedication to medical innovation. His work at Jw Pharmaceutical Corporation and collaborations with esteemed colleagues further highlight his impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile